AGIO:NASDAQ
Agios Pharmaceuticals Inc
$33.10
arrow_downward
-0.09%(-0.030) 1D
$33.10
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Set 4, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AGIO...
Buksan
$33.13
Mataas
$33.50
Mababa
$32.92
Mkt. cap
1.98B
Avg. na dami
1.08M
Dami
480.16K
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Buksan
$33.13
Mataas
$33.50
Mababa
$32.92
Mkt. cap
1.98B
Avg. na dami
1.08M
Dami
480.16K
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Zacks
·
10 oras ang nakalipas
Revolution Medicines (RVMD) Up 6.6% Since Last Earnings Report: Can It Continue?
https://www.dars.gov.et/
·
1 linggo ang nakalipas
AGIO Q2 2026 Earnings: Narrower-Than-Expected Loss Fails to Halt Share Decline - Profit Recovery Report
https://www.dars.gov.et/
·
1 linggo ang nakalipas
Agios (AGIO) Earnings Report: EPS Comes in Above Forecast in the Current Update; Share Move: The Market Price Declines 1.61% - Earnings Volatility Report
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tungkol sa Agios Pharmaceuticals Inc